nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamsulosin—Rhinorrhoea—Sorafenib—liver cancer	0.0188	0.0256	CcSEcCtD
Tamsulosin—Drug interaction—Sorafenib—liver cancer	0.0164	0.0224	CcSEcCtD
Tamsulosin—Influenza like illness—Sorafenib—liver cancer	0.0148	0.0201	CcSEcCtD
Tamsulosin—Skin exfoliation—Sorafenib—liver cancer	0.0145	0.0198	CcSEcCtD
Tamsulosin—Carvedilol—VEGFA—liver cancer	0.0131	0.507	CrCbGaD
Tamsulosin—Dermatitis exfoliative—Sorafenib—liver cancer	0.0117	0.016	CcSEcCtD
Tamsulosin—Breast disorder—Sorafenib—liver cancer	0.00998	0.0136	CcSEcCtD
Tamsulosin—Nasopharyngitis—Sorafenib—liver cancer	0.00987	0.0135	CcSEcCtD
Tamsulosin—Erectile dysfunction—Sorafenib—liver cancer	0.00879	0.012	CcSEcCtD
Tamsulosin—Infestation—Sorafenib—liver cancer	0.00851	0.0116	CcSEcCtD
Tamsulosin—Infestation NOS—Sorafenib—liver cancer	0.00851	0.0116	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00844	0.0115	CcSEcCtD
Tamsulosin—Epistaxis—Sorafenib—liver cancer	0.00803	0.0109	CcSEcCtD
Tamsulosin—Lung disorder—Epirubicin—liver cancer	0.00794	0.0108	CcSEcCtD
Tamsulosin—Connective tissue disorder—Sorafenib—liver cancer	0.00751	0.0102	CcSEcCtD
Tamsulosin—Lung disorder—Doxorubicin—liver cancer	0.00735	0.01	CcSEcCtD
Tamsulosin—Amblyopia—Epirubicin—liver cancer	0.00728	0.00993	CcSEcCtD
Tamsulosin—Erythema multiforme—Sorafenib—liver cancer	0.00722	0.00985	CcSEcCtD
Tamsulosin—Cardiac disorder—Sorafenib—liver cancer	0.00709	0.00967	CcSEcCtD
Tamsulosin—Angiopathy—Sorafenib—liver cancer	0.00693	0.00945	CcSEcCtD
Tamsulosin—Mediastinal disorder—Sorafenib—liver cancer	0.00689	0.00939	CcSEcCtD
Tamsulosin—Arrhythmia—Sorafenib—liver cancer	0.00682	0.0093	CcSEcCtD
Tamsulosin—Amblyopia—Doxorubicin—liver cancer	0.00674	0.00918	CcSEcCtD
Tamsulosin—Malnutrition—Sorafenib—liver cancer	0.00665	0.00907	CcSEcCtD
Tamsulosin—Carvedilol—CYP2E1—liver cancer	0.00642	0.248	CrCbGaD
Tamsulosin—Carvedilol—CYP1A1—liver cancer	0.00633	0.245	CrCbGaD
Tamsulosin—Cough increased—Epirubicin—liver cancer	0.00614	0.00837	CcSEcCtD
Tamsulosin—Angioedema—Sorafenib—liver cancer	0.00608	0.00828	CcSEcCtD
Tamsulosin—Syncope—Sorafenib—liver cancer	0.00596	0.00813	CcSEcCtD
Tamsulosin—Loss of consciousness—Sorafenib—liver cancer	0.00585	0.00797	CcSEcCtD
Tamsulosin—Cough—Sorafenib—liver cancer	0.0058	0.00791	CcSEcCtD
Tamsulosin—Hypertension—Sorafenib—liver cancer	0.00574	0.00783	CcSEcCtD
Tamsulosin—Neck pain—Epirubicin—liver cancer	0.00569	0.00776	CcSEcCtD
Tamsulosin—Cough increased—Doxorubicin—liver cancer	0.00568	0.00775	CcSEcCtD
Tamsulosin—Myalgia—Sorafenib—liver cancer	0.00566	0.00772	CcSEcCtD
Tamsulosin—Arthralgia—Sorafenib—liver cancer	0.00566	0.00772	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00562	0.00767	CcSEcCtD
Tamsulosin—Influenza like illness—Epirubicin—liver cancer	0.00546	0.00744	CcSEcCtD
Tamsulosin—Infection—Sorafenib—liver cancer	0.00539	0.00735	CcSEcCtD
Tamsulosin—Skin exfoliation—Epirubicin—liver cancer	0.00537	0.00732	CcSEcCtD
Tamsulosin—Shock—Sorafenib—liver cancer	0.00534	0.00728	CcSEcCtD
Tamsulosin—Nervous system disorder—Sorafenib—liver cancer	0.00532	0.00726	CcSEcCtD
Tamsulosin—Skin disorder—Sorafenib—liver cancer	0.00527	0.00719	CcSEcCtD
Tamsulosin—Neck pain—Doxorubicin—liver cancer	0.00527	0.00718	CcSEcCtD
Tamsulosin—Influenza like illness—Doxorubicin—liver cancer	0.00505	0.00689	CcSEcCtD
Tamsulosin—Skin exfoliation—Doxorubicin—liver cancer	0.00497	0.00677	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00494	0.00674	CcSEcCtD
Tamsulosin—Hypertonia—Epirubicin—liver cancer	0.00493	0.00672	CcSEcCtD
Tamsulosin—Dyspnoea—Sorafenib—liver cancer	0.00484	0.0066	CcSEcCtD
Tamsulosin—Dyspepsia—Sorafenib—liver cancer	0.00478	0.00651	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00469	0.00639	CcSEcCtD
Tamsulosin—Fatigue—Sorafenib—liver cancer	0.00468	0.00638	CcSEcCtD
Tamsulosin—Pain—Sorafenib—liver cancer	0.00464	0.00633	CcSEcCtD
Tamsulosin—Constipation—Sorafenib—liver cancer	0.00464	0.00633	CcSEcCtD
Tamsulosin—Hypertonia—Doxorubicin—liver cancer	0.00456	0.00622	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Sorafenib—liver cancer	0.00444	0.00605	CcSEcCtD
Tamsulosin—Dermatitis exfoliative—Epirubicin—liver cancer	0.00433	0.0059	CcSEcCtD
Tamsulosin—Urticaria—Sorafenib—liver cancer	0.00431	0.00588	CcSEcCtD
Tamsulosin—Body temperature increased—Sorafenib—liver cancer	0.00429	0.00585	CcSEcCtD
Tamsulosin—Abdominal pain—Sorafenib—liver cancer	0.00429	0.00585	CcSEcCtD
Tamsulosin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.004	0.00546	CcSEcCtD
Tamsulosin—Hypersensitivity—Sorafenib—liver cancer	0.004	0.00545	CcSEcCtD
Tamsulosin—Asthenia—Sorafenib—liver cancer	0.00389	0.00531	CcSEcCtD
Tamsulosin—Pruritus—Sorafenib—liver cancer	0.00384	0.00524	CcSEcCtD
Tamsulosin—Orthostatic hypotension—Epirubicin—liver cancer	0.00373	0.00508	CcSEcCtD
Tamsulosin—Diarrhoea—Sorafenib—liver cancer	0.00371	0.00506	CcSEcCtD
Tamsulosin—Breast disorder—Epirubicin—liver cancer	0.00369	0.00503	CcSEcCtD
Tamsulosin—Nasopharyngitis—Epirubicin—liver cancer	0.00365	0.00498	CcSEcCtD
Tamsulosin—Dizziness—Sorafenib—liver cancer	0.00359	0.00489	CcSEcCtD
Tamsulosin—Influenza—Epirubicin—liver cancer	0.00353	0.00481	CcSEcCtD
Tamsulosin—Vomiting—Sorafenib—liver cancer	0.00345	0.0047	CcSEcCtD
Tamsulosin—Orthostatic hypotension—Doxorubicin—liver cancer	0.00345	0.0047	CcSEcCtD
Tamsulosin—Rash—Sorafenib—liver cancer	0.00342	0.00467	CcSEcCtD
Tamsulosin—Dermatitis—Sorafenib—liver cancer	0.00342	0.00466	CcSEcCtD
Tamsulosin—Breast disorder—Doxorubicin—liver cancer	0.00341	0.00465	CcSEcCtD
Tamsulosin—Headache—Sorafenib—liver cancer	0.0034	0.00464	CcSEcCtD
Tamsulosin—Nasopharyngitis—Doxorubicin—liver cancer	0.00338	0.0046	CcSEcCtD
Tamsulosin—Dysuria—Epirubicin—liver cancer	0.0033	0.0045	CcSEcCtD
Tamsulosin—Influenza—Doxorubicin—liver cancer	0.00326	0.00445	CcSEcCtD
Tamsulosin—Nausea—Sorafenib—liver cancer	0.00322	0.0044	CcSEcCtD
Tamsulosin—Infestation NOS—Epirubicin—liver cancer	0.00315	0.00429	CcSEcCtD
Tamsulosin—Infestation—Epirubicin—liver cancer	0.00315	0.00429	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00312	0.00425	CcSEcCtD
Tamsulosin—Urinary tract infection—Epirubicin—liver cancer	0.00306	0.00417	CcSEcCtD
Tamsulosin—Dysuria—Doxorubicin—liver cancer	0.00305	0.00416	CcSEcCtD
Tamsulosin—Sweating—Epirubicin—liver cancer	0.00302	0.00411	CcSEcCtD
Tamsulosin—Epistaxis—Epirubicin—liver cancer	0.00297	0.00404	CcSEcCtD
Tamsulosin—Sinusitis—Epirubicin—liver cancer	0.00295	0.00402	CcSEcCtD
Tamsulosin—Infestation NOS—Doxorubicin—liver cancer	0.00291	0.00397	CcSEcCtD
Tamsulosin—Infestation—Doxorubicin—liver cancer	0.00291	0.00397	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00289	0.00393	CcSEcCtD
Tamsulosin—Rhinitis—Epirubicin—liver cancer	0.00283	0.00386	CcSEcCtD
Tamsulosin—Urinary tract infection—Doxorubicin—liver cancer	0.00283	0.00386	CcSEcCtD
Tamsulosin—Pharyngitis—Epirubicin—liver cancer	0.0028	0.00382	CcSEcCtD
Tamsulosin—Sweating—Doxorubicin—liver cancer	0.00279	0.0038	CcSEcCtD
Tamsulosin—Oedema peripheral—Epirubicin—liver cancer	0.00278	0.00379	CcSEcCtD
Tamsulosin—Connective tissue disorder—Epirubicin—liver cancer	0.00277	0.00378	CcSEcCtD
Tamsulosin—Epistaxis—Doxorubicin—liver cancer	0.00274	0.00374	CcSEcCtD
Tamsulosin—Sinusitis—Doxorubicin—liver cancer	0.00273	0.00372	CcSEcCtD
Tamsulosin—Visual impairment—Epirubicin—liver cancer	0.00272	0.00371	CcSEcCtD
Tamsulosin—Erythema multiforme—Epirubicin—liver cancer	0.00267	0.00364	CcSEcCtD
Tamsulosin—Cardiac disorder—Epirubicin—liver cancer	0.00262	0.00357	CcSEcCtD
Tamsulosin—Rhinitis—Doxorubicin—liver cancer	0.00262	0.00357	CcSEcCtD
Tamsulosin—Pharyngitis—Doxorubicin—liver cancer	0.00259	0.00353	CcSEcCtD
Tamsulosin—Oedema peripheral—Doxorubicin—liver cancer	0.00257	0.00351	CcSEcCtD
Tamsulosin—Connective tissue disorder—Doxorubicin—liver cancer	0.00257	0.0035	CcSEcCtD
Tamsulosin—Angiopathy—Epirubicin—liver cancer	0.00256	0.00349	CcSEcCtD
Tamsulosin—Mediastinal disorder—Epirubicin—liver cancer	0.00254	0.00347	CcSEcCtD
Tamsulosin—Chills—Epirubicin—liver cancer	0.00253	0.00345	CcSEcCtD
Tamsulosin—Arrhythmia—Epirubicin—liver cancer	0.00252	0.00344	CcSEcCtD
Tamsulosin—Visual impairment—Doxorubicin—liver cancer	0.00252	0.00343	CcSEcCtD
Tamsulosin—Erythema multiforme—Doxorubicin—liver cancer	0.00247	0.00337	CcSEcCtD
Tamsulosin—Malnutrition—Epirubicin—liver cancer	0.00246	0.00335	CcSEcCtD
Tamsulosin—Cardiac disorder—Doxorubicin—liver cancer	0.00242	0.00331	CcSEcCtD
Tamsulosin—Back pain—Epirubicin—liver cancer	0.00238	0.00324	CcSEcCtD
Tamsulosin—Angiopathy—Doxorubicin—liver cancer	0.00237	0.00323	CcSEcCtD
Tamsulosin—Mediastinal disorder—Doxorubicin—liver cancer	0.00235	0.00321	CcSEcCtD
Tamsulosin—Chills—Doxorubicin—liver cancer	0.00234	0.0032	CcSEcCtD
Tamsulosin—Arrhythmia—Doxorubicin—liver cancer	0.00233	0.00318	CcSEcCtD
Tamsulosin—Vision blurred—Epirubicin—liver cancer	0.00232	0.00316	CcSEcCtD
Tamsulosin—Ill-defined disorder—Epirubicin—liver cancer	0.00228	0.00311	CcSEcCtD
Tamsulosin—Malnutrition—Doxorubicin—liver cancer	0.00227	0.0031	CcSEcCtD
Tamsulosin—Malaise—Epirubicin—liver cancer	0.00222	0.00302	CcSEcCtD
Tamsulosin—Vertigo—Epirubicin—liver cancer	0.00221	0.00301	CcSEcCtD
Tamsulosin—Syncope—Epirubicin—liver cancer	0.0022	0.003	CcSEcCtD
Tamsulosin—Back pain—Doxorubicin—liver cancer	0.0022	0.003	CcSEcCtD
Tamsulosin—Palpitations—Epirubicin—liver cancer	0.00217	0.00296	CcSEcCtD
Tamsulosin—Loss of consciousness—Epirubicin—liver cancer	0.00216	0.00295	CcSEcCtD
Tamsulosin—Cough—Epirubicin—liver cancer	0.00214	0.00292	CcSEcCtD
Tamsulosin—Vision blurred—Doxorubicin—liver cancer	0.00214	0.00292	CcSEcCtD
Tamsulosin—Hypertension—Epirubicin—liver cancer	0.00212	0.00289	CcSEcCtD
Tamsulosin—Ill-defined disorder—Doxorubicin—liver cancer	0.00211	0.00288	CcSEcCtD
Tamsulosin—Arthralgia—Epirubicin—liver cancer	0.00209	0.00285	CcSEcCtD
Tamsulosin—Chest pain—Epirubicin—liver cancer	0.00209	0.00285	CcSEcCtD
Tamsulosin—Myalgia—Epirubicin—liver cancer	0.00209	0.00285	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00208	0.00283	CcSEcCtD
Tamsulosin—Discomfort—Epirubicin—liver cancer	0.00207	0.00282	CcSEcCtD
Tamsulosin—Malaise—Doxorubicin—liver cancer	0.00205	0.0028	CcSEcCtD
Tamsulosin—Vertigo—Doxorubicin—liver cancer	0.00204	0.00279	CcSEcCtD
Tamsulosin—Syncope—Doxorubicin—liver cancer	0.00204	0.00278	CcSEcCtD
Tamsulosin—Palpitations—Doxorubicin—liver cancer	0.00201	0.00274	CcSEcCtD
Tamsulosin—Loss of consciousness—Doxorubicin—liver cancer	0.002	0.00273	CcSEcCtD
Tamsulosin—Infection—Epirubicin—liver cancer	0.00199	0.00272	CcSEcCtD
Tamsulosin—Cough—Doxorubicin—liver cancer	0.00198	0.00271	CcSEcCtD
Tamsulosin—Shock—Epirubicin—liver cancer	0.00197	0.00269	CcSEcCtD
Tamsulosin—Nervous system disorder—Epirubicin—liver cancer	0.00197	0.00268	CcSEcCtD
Tamsulosin—Hypertension—Doxorubicin—liver cancer	0.00196	0.00268	CcSEcCtD
Tamsulosin—Tachycardia—Epirubicin—liver cancer	0.00196	0.00267	CcSEcCtD
Tamsulosin—Skin disorder—Epirubicin—liver cancer	0.00195	0.00266	CcSEcCtD
Tamsulosin—Hyperhidrosis—Epirubicin—liver cancer	0.00194	0.00264	CcSEcCtD
Tamsulosin—Arthralgia—Doxorubicin—liver cancer	0.00194	0.00264	CcSEcCtD
Tamsulosin—Chest pain—Doxorubicin—liver cancer	0.00194	0.00264	CcSEcCtD
Tamsulosin—Myalgia—Doxorubicin—liver cancer	0.00194	0.00264	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00192	0.00262	CcSEcCtD
Tamsulosin—Discomfort—Doxorubicin—liver cancer	0.00191	0.00261	CcSEcCtD
Tamsulosin—Hypotension—Epirubicin—liver cancer	0.00187	0.00256	CcSEcCtD
Tamsulosin—Infection—Doxorubicin—liver cancer	0.00184	0.00251	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00183	0.00249	CcSEcCtD
Tamsulosin—Shock—Doxorubicin—liver cancer	0.00183	0.00249	CcSEcCtD
Tamsulosin—Nervous system disorder—Doxorubicin—liver cancer	0.00182	0.00248	CcSEcCtD
Tamsulosin—Insomnia—Epirubicin—liver cancer	0.00181	0.00247	CcSEcCtD
Tamsulosin—Tachycardia—Doxorubicin—liver cancer	0.00181	0.00247	CcSEcCtD
Tamsulosin—Skin disorder—Doxorubicin—liver cancer	0.0018	0.00246	CcSEcCtD
Tamsulosin—Paraesthesia—Epirubicin—liver cancer	0.0018	0.00246	CcSEcCtD
Tamsulosin—Hyperhidrosis—Doxorubicin—liver cancer	0.00179	0.00245	CcSEcCtD
Tamsulosin—Dyspnoea—Epirubicin—liver cancer	0.00179	0.00244	CcSEcCtD
Tamsulosin—Somnolence—Epirubicin—liver cancer	0.00178	0.00243	CcSEcCtD
Tamsulosin—Dyspepsia—Epirubicin—liver cancer	0.00177	0.00241	CcSEcCtD
Tamsulosin—Hypotension—Doxorubicin—liver cancer	0.00173	0.00236	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00173	0.00236	CcSEcCtD
Tamsulosin—Fatigue—Epirubicin—liver cancer	0.00173	0.00236	CcSEcCtD
Tamsulosin—Pain—Epirubicin—liver cancer	0.00172	0.00234	CcSEcCtD
Tamsulosin—Constipation—Epirubicin—liver cancer	0.00172	0.00234	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00169	0.00231	CcSEcCtD
Tamsulosin—Insomnia—Doxorubicin—liver cancer	0.00168	0.00229	CcSEcCtD
Tamsulosin—Paraesthesia—Doxorubicin—liver cancer	0.00167	0.00227	CcSEcCtD
Tamsulosin—Dyspnoea—Doxorubicin—liver cancer	0.00165	0.00226	CcSEcCtD
Tamsulosin—Feeling abnormal—Epirubicin—liver cancer	0.00165	0.00225	CcSEcCtD
Tamsulosin—Somnolence—Doxorubicin—liver cancer	0.00165	0.00225	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Epirubicin—liver cancer	0.00164	0.00224	CcSEcCtD
Tamsulosin—Dyspepsia—Doxorubicin—liver cancer	0.00163	0.00223	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.0016	0.00218	CcSEcCtD
Tamsulosin—Fatigue—Doxorubicin—liver cancer	0.0016	0.00218	CcSEcCtD
Tamsulosin—Urticaria—Epirubicin—liver cancer	0.00159	0.00217	CcSEcCtD
Tamsulosin—Pain—Doxorubicin—liver cancer	0.00159	0.00216	CcSEcCtD
Tamsulosin—Constipation—Doxorubicin—liver cancer	0.00159	0.00216	CcSEcCtD
Tamsulosin—Abdominal pain—Epirubicin—liver cancer	0.00159	0.00216	CcSEcCtD
Tamsulosin—Body temperature increased—Epirubicin—liver cancer	0.00159	0.00216	CcSEcCtD
Tamsulosin—Feeling abnormal—Doxorubicin—liver cancer	0.00153	0.00209	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Doxorubicin—liver cancer	0.00152	0.00207	CcSEcCtD
Tamsulosin—Hypersensitivity—Epirubicin—liver cancer	0.00148	0.00201	CcSEcCtD
Tamsulosin—Urticaria—Doxorubicin—liver cancer	0.00147	0.00201	CcSEcCtD
Tamsulosin—Body temperature increased—Doxorubicin—liver cancer	0.00147	0.002	CcSEcCtD
Tamsulosin—Abdominal pain—Doxorubicin—liver cancer	0.00147	0.002	CcSEcCtD
Tamsulosin—Asthenia—Epirubicin—liver cancer	0.00144	0.00196	CcSEcCtD
Tamsulosin—Pruritus—Epirubicin—liver cancer	0.00142	0.00193	CcSEcCtD
Tamsulosin—Diarrhoea—Epirubicin—liver cancer	0.00137	0.00187	CcSEcCtD
Tamsulosin—Hypersensitivity—Doxorubicin—liver cancer	0.00137	0.00186	CcSEcCtD
Tamsulosin—Asthenia—Doxorubicin—liver cancer	0.00133	0.00182	CcSEcCtD
Tamsulosin—Dizziness—Epirubicin—liver cancer	0.00133	0.00181	CcSEcCtD
Tamsulosin—Pruritus—Doxorubicin—liver cancer	0.00131	0.00179	CcSEcCtD
Tamsulosin—Vomiting—Epirubicin—liver cancer	0.00128	0.00174	CcSEcCtD
Tamsulosin—Diarrhoea—Doxorubicin—liver cancer	0.00127	0.00173	CcSEcCtD
Tamsulosin—Rash—Epirubicin—liver cancer	0.00126	0.00172	CcSEcCtD
Tamsulosin—Dermatitis—Epirubicin—liver cancer	0.00126	0.00172	CcSEcCtD
Tamsulosin—Headache—Epirubicin—liver cancer	0.00126	0.00171	CcSEcCtD
Tamsulosin—Dizziness—Doxorubicin—liver cancer	0.00123	0.00167	CcSEcCtD
Tamsulosin—Nausea—Epirubicin—liver cancer	0.00119	0.00162	CcSEcCtD
Tamsulosin—Vomiting—Doxorubicin—liver cancer	0.00118	0.00161	CcSEcCtD
Tamsulosin—Rash—Doxorubicin—liver cancer	0.00117	0.0016	CcSEcCtD
Tamsulosin—Dermatitis—Doxorubicin—liver cancer	0.00117	0.00159	CcSEcCtD
Tamsulosin—Headache—Doxorubicin—liver cancer	0.00116	0.00159	CcSEcCtD
Tamsulosin—Nausea—Doxorubicin—liver cancer	0.0011	0.0015	CcSEcCtD
Tamsulosin—ADRA1D—Signaling by GPCR—HRAS—liver cancer	4.43e-05	0.000184	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—HRAS—liver cancer	4.43e-05	0.000184	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	4.42e-05	0.000184	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—ESR1—liver cancer	4.39e-05	0.000182	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	4.38e-05	0.000182	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	4.37e-05	0.000182	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CD—liver cancer	4.36e-05	0.000181	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—BRAF—liver cancer	4.36e-05	0.000181	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CDKN1B—liver cancer	4.36e-05	0.000181	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—CDKN1B—liver cancer	4.36e-05	0.000181	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—GSTM1—liver cancer	4.35e-05	0.000181	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—F2—liver cancer	4.34e-05	0.00018	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—KRAS—liver cancer	4.33e-05	0.00018	CbGpPWpGaD
Tamsulosin—ADRA1D—GPCR downstream signaling—AKT1—liver cancer	4.31e-05	0.000179	CbGpPWpGaD
Tamsulosin—DRD3—GPCR downstream signaling—AKT1—liver cancer	4.31e-05	0.000179	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—ALB—liver cancer	4.31e-05	0.000179	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—CASP3—liver cancer	4.27e-05	0.000177	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CASP3—liver cancer	4.27e-05	0.000177	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IL2—liver cancer	4.26e-05	0.000177	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IL2—liver cancer	4.26e-05	0.000177	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—VEGFA—liver cancer	4.26e-05	0.000177	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—IL6—liver cancer	4.24e-05	0.000176	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—IL6—liver cancer	4.24e-05	0.000176	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—STAT3—liver cancer	4.22e-05	0.000175	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—BRAF—liver cancer	4.2e-05	0.000174	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—PIK3CA—liver cancer	4.17e-05	0.000173	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—CCND1—liver cancer	4.16e-05	0.000173	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CCND1—liver cancer	4.16e-05	0.000173	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CG—liver cancer	4.15e-05	0.000172	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—APC—liver cancer	4.15e-05	0.000172	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—JUN—liver cancer	4.15e-05	0.000172	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—JUN—liver cancer	4.15e-05	0.000172	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—RAF1—liver cancer	4.14e-05	0.000172	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—CYP1A1—liver cancer	4.13e-05	0.000172	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CTNNB1—liver cancer	4.12e-05	0.000171	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—CTNNB1—liver cancer	4.12e-05	0.000171	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PSMA4—liver cancer	4.11e-05	0.000171	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PSMD10—liver cancer	4.11e-05	0.000171	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CD—liver cancer	4.07e-05	0.000169	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MTOR—liver cancer	4.05e-05	0.000168	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PIK3CB—liver cancer	4.05e-05	0.000168	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	4.04e-05	0.000168	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MMP9—liver cancer	4.03e-05	0.000168	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MMP9—liver cancer	4.03e-05	0.000168	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—SERPINE1—liver cancer	4.03e-05	0.000167	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—CDKN1A—liver cancer	4.02e-05	0.000167	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CDKN1A—liver cancer	4.02e-05	0.000167	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GOT2—liver cancer	4e-05	0.000166	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—KRAS—liver cancer	3.99e-05	0.000166	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	3.98e-05	0.000165	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—RAF1—liver cancer	3.95e-05	0.000164	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	3.93e-05	0.000163	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MAPK8—liver cancer	3.92e-05	0.000163	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MAPK8—liver cancer	3.92e-05	0.000163	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MYC—liver cancer	3.92e-05	0.000163	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—AKT1—liver cancer	3.91e-05	0.000163	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—AKT1—liver cancer	3.91e-05	0.000163	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TGFB1—liver cancer	3.91e-05	0.000162	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—BRAF—liver cancer	3.9e-05	0.000162	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	3.89e-05	0.000162	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	3.88e-05	0.000161	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—HRAS—liver cancer	3.86e-05	0.00016	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MTOR—liver cancer	3.85e-05	0.00016	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	3.85e-05	0.00016	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—MTHFR—liver cancer	3.85e-05	0.00016	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—KRAS—liver cancer	3.84e-05	0.00016	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CB—liver cancer	3.8e-05	0.000158	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1B—liver cancer	3.8e-05	0.000158	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PPARA—liver cancer	3.78e-05	0.000157	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP2E1—liver cancer	3.76e-05	0.000156	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—AKT1—liver cancer	3.76e-05	0.000156	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CASP3—liver cancer	3.72e-05	0.000155	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL2—liver cancer	3.72e-05	0.000154	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—IL6—liver cancer	3.7e-05	0.000154	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—HRAS—liver cancer	3.68e-05	0.000153	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—PIK3CA—liver cancer	3.67e-05	0.000152	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	3.65e-05	0.000152	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—RAF1—liver cancer	3.64e-05	0.000151	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—VEGFA—liver cancer	3.62e-05	0.000151	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—VEGFA—liver cancer	3.62e-05	0.000151	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—KRAS—liver cancer	3.62e-05	0.000151	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CCND1—liver cancer	3.62e-05	0.00015	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	3.62e-05	0.00015	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—JUN—liver cancer	3.61e-05	0.00015	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	3.61e-05	0.00015	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	3.61e-05	0.00015	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—STAT3—liver cancer	3.59e-05	0.000149	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—STAT3—liver cancer	3.59e-05	0.000149	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CTNNB1—liver cancer	3.59e-05	0.000149	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	3.58e-05	0.000149	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—KRAS—liver cancer	3.57e-05	0.000148	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CB—liver cancer	3.55e-05	0.000148	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MTOR—liver cancer	3.55e-05	0.000148	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CASP3—liver cancer	3.54e-05	0.000147	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL2—liver cancer	3.54e-05	0.000147	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	3.53e-05	0.000147	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—IL6—liver cancer	3.52e-05	0.000146	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MMP9—liver cancer	3.52e-05	0.000146	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYCS—liver cancer	3.52e-05	0.000146	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—RAF1—liver cancer	3.5e-05	0.000146	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1A—liver cancer	3.5e-05	0.000146	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GGT1—liver cancer	3.45e-05	0.000143	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GOT1—liver cancer	3.45e-05	0.000143	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CCND1—liver cancer	3.45e-05	0.000143	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—JUN—liver cancer	3.44e-05	0.000143	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	3.42e-05	0.000142	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MTOR—liver cancer	3.42e-05	0.000142	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MAPK8—liver cancer	3.42e-05	0.000142	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	3.42e-05	0.000142	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—AKT1—liver cancer	3.41e-05	0.000142	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—HRAS—liver cancer	3.39e-05	0.000141	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MMP9—liver cancer	3.35e-05	0.000139	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	3.34e-05	0.000139	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MYC—liver cancer	3.33e-05	0.000139	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MYC—liver cancer	3.33e-05	0.000139	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1B—liver cancer	3.33e-05	0.000139	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—PIK3CA—liver cancer	3.33e-05	0.000138	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TGFB1—liver cancer	3.33e-05	0.000138	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TGFB1—liver cancer	3.33e-05	0.000138	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—AKT1—liver cancer	3.3e-05	0.000137	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	3.28e-05	0.000136	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—HRAS—liver cancer	3.27e-05	0.000136	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CASP3—liver cancer	3.27e-05	0.000136	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL2—liver cancer	3.26e-05	0.000136	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MAPK8—liver cancer	3.26e-05	0.000135	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—RAF1—liver cancer	3.26e-05	0.000135	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—AKT1—liver cancer	3.25e-05	0.000135	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—IL6—liver cancer	3.25e-05	0.000135	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CG—liver cancer	3.23e-05	0.000134	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TP53—liver cancer	3.22e-05	0.000134	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	3.21e-05	0.000133	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CCND1—liver cancer	3.18e-05	0.000132	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MTOR—liver cancer	3.18e-05	0.000132	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	3.18e-05	0.000132	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	3.18e-05	0.000132	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—JUN—liver cancer	3.17e-05	0.000132	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—VEGFA—liver cancer	3.16e-05	0.000131	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CTNNB1—liver cancer	3.15e-05	0.000131	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CASP3—liver cancer	3.15e-05	0.000131	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL2—liver cancer	3.14e-05	0.000131	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—IL6—liver cancer	3.13e-05	0.00013	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—STAT3—liver cancer	3.13e-05	0.00013	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PPARG—liver cancer	3.12e-05	0.00013	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTP1—liver cancer	3.1e-05	0.000129	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MMP9—liver cancer	3.09e-05	0.000128	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—KRAS—liver cancer	3.08e-05	0.000128	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—KRAS—liver cancer	3.08e-05	0.000128	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—HRAS—liver cancer	3.08e-05	0.000128	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1A—liver cancer	3.08e-05	0.000128	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CCND1—liver cancer	3.06e-05	0.000127	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—JUN—liver cancer	3.06e-05	0.000127	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—HMOX1—liver cancer	3.06e-05	0.000127	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—HRAS—liver cancer	3.04e-05	0.000126	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	3.03e-05	0.000126	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—VEGFA—liver cancer	3.01e-05	0.000125	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MAPK8—liver cancer	3e-05	0.000125	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—AKT1—liver cancer	2.99e-05	0.000124	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	2.98e-05	0.000124	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—STAT3—liver cancer	2.98e-05	0.000124	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MMP9—liver cancer	2.97e-05	0.000124	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	2.96e-05	0.000123	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	2.95e-05	0.000123	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—IL6—liver cancer	2.95e-05	0.000122	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CASP3—liver cancer	2.92e-05	0.000122	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL2—liver cancer	2.92e-05	0.000121	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—IL6—liver cancer	2.91e-05	0.000121	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MYC—liver cancer	2.9e-05	0.000121	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TGFB1—liver cancer	2.9e-05	0.00012	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAPK8—liver cancer	2.89e-05	0.00012	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—AKT1—liver cancer	2.88e-05	0.00012	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTM1—liver cancer	2.85e-05	0.000118	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CCND1—liver cancer	2.85e-05	0.000118	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CD—liver cancer	2.84e-05	0.000118	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—JUN—liver cancer	2.84e-05	0.000118	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	2.83e-05	0.000118	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PIK3CA—liver cancer	2.83e-05	0.000118	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	2.82e-05	0.000117	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—ALB—liver cancer	2.81e-05	0.000117	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—VEGFA—liver cancer	2.77e-05	0.000115	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MYC—liver cancer	2.77e-05	0.000115	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MMP9—liver cancer	2.76e-05	0.000115	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TGFB1—liver cancer	2.76e-05	0.000115	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	2.75e-05	0.000114	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—STAT3—liver cancer	2.74e-05	0.000114	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TP53—liver cancer	2.74e-05	0.000114	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TP53—liver cancer	2.74e-05	0.000114	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—AKT1—liver cancer	2.72e-05	0.000113	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP1A1—liver cancer	2.7e-05	0.000112	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAPK8—liver cancer	2.69e-05	0.000112	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—KRAS—liver cancer	2.68e-05	0.000112	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—AKT1—liver cancer	2.68e-05	0.000111	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—VEGFA—liver cancer	2.67e-05	0.000111	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—STAT3—liver cancer	2.64e-05	0.00011	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—HRAS—liver cancer	2.62e-05	0.000109	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—HRAS—liver cancer	2.62e-05	0.000109	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—KRAS—liver cancer	2.56e-05	0.000106	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MYC—liver cancer	2.55e-05	0.000106	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TGFB1—liver cancer	2.54e-05	0.000106	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—MTHFR—liver cancer	2.52e-05	0.000105	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IL6—liver cancer	2.51e-05	0.000104	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IL6—liver cancer	2.51e-05	0.000104	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—VEGFA—liver cancer	2.48e-05	0.000103	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CB—liver cancer	2.48e-05	0.000103	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PPARA—liver cancer	2.47e-05	0.000103	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PIK3CA—liver cancer	2.47e-05	0.000102	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MYC—liver cancer	2.46e-05	0.000102	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—STAT3—liver cancer	2.46e-05	0.000102	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TGFB1—liver cancer	2.45e-05	0.000102	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TP53—liver cancer	2.39e-05	9.91e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—KRAS—liver cancer	2.36e-05	9.79e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	2.35e-05	9.76e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CA—liver cancer	2.32e-05	9.63e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—AKT1—liver cancer	2.31e-05	9.6e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—AKT1—liver cancer	2.31e-05	9.6e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MYC—liver cancer	2.28e-05	9.49e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—HRAS—liver cancer	2.28e-05	9.48e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TGFB1—liver cancer	2.28e-05	9.46e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TP53—liver cancer	2.27e-05	9.44e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—KRAS—liver cancer	2.27e-05	9.43e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL6—liver cancer	2.18e-05	9.07e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—HRAS—liver cancer	2.17e-05	9.03e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CA—liver cancer	2.17e-05	9e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CG—liver cancer	2.11e-05	8.78e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—KRAS—liver cancer	2.11e-05	8.77e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TP53—liver cancer	2.09e-05	8.7e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	2.09e-05	8.67e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL6—liver cancer	2.08e-05	8.64e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PPARG—liver cancer	2.04e-05	8.48e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TP53—liver cancer	2.02e-05	8.39e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—AKT1—liver cancer	2.01e-05	8.37e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—HRAS—liver cancer	2e-05	8.32e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	1.94e-05	8.05e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—HRAS—liver cancer	1.93e-05	8.02e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—AKT1—liver cancer	1.92e-05	7.97e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL6—liver cancer	1.92e-05	7.97e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—AKT1—liver cancer	1.89e-05	7.87e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TP53—liver cancer	1.88e-05	7.79e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CD—liver cancer	1.86e-05	7.72e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL6—liver cancer	1.85e-05	7.68e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ALB—liver cancer	1.83e-05	7.62e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—HRAS—liver cancer	1.79e-05	7.45e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—AKT1—liver cancer	1.77e-05	7.35e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL6—liver cancer	1.72e-05	7.13e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—AKT1—liver cancer	1.7e-05	7.08e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CB—liver cancer	1.62e-05	6.73e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—AKT1—liver cancer	1.58e-05	6.58e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CA—liver cancer	1.51e-05	6.28e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—AKT1—liver cancer	1.23e-05	5.13e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CA—liver cancer	9.88e-06	4.1e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—AKT1—liver cancer	8.07e-06	3.35e-05	CbGpPWpGaD
